Main Menu

The goal of the Illuminating the Druggable Genome (IDG) program is to improve our understanding of the properties and functions of proteins that are currently unannotated within the three most commonly drug-targeted protein families: G-protein coupled receptors, ion channels, and protein kinases.


The Protein Illumination timeline describes the progress made in illuminating these dark proteins. The illumination is measured in terms of generated reagents and data associated with the understudied targets.